Opinion

Video

Out of Pocket Costs Associated with Biosimilar Use

The panel discusses out of pocket costs and the impact of the 340b program for various patient types.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
1 expert is featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo